Stromal cells and integrins: Conforming to the needs of the tumor microenvironment

Neoplasia

Volumn 11, Issue 12, 2009, Pages 1264-1271

  Alphonso, Aimee ^a   Alahari, Suresh K ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CXCR4; INTEGRIN; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANGIOGENESIS; CANCER INHIBITION; CANCER INVASION; CELL INTERACTION; CELL SURVIVAL; CELL TYPE; EPIGENETICS; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; IMMUNOCOMPETENT CELL; MACROPHAGE; METASTASIS; MICROENVIRONMENT; MUTATION; PARACRINE SIGNALING; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STROMA CELL; TUMOR; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL; TUMOR GROWTH;

EID: 72949113024     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.91302     Document Type: Article

References (69)

1. McDonald DM and Baluk P (2002). Significance of blood vessel leakiness in cancer. Cancer Res 62, 5381-5385.
2. Hashizume H, Baluk P,Morikawa S,McLean JW, Thurston G, Roberge S, Jain RK, and McDonald DM (2000). Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 156, 1363-1380.
3. Liotta LA, Steeg PS, and Stetler-Stevenson WG (1991). Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64, 327-336.
4. Mendoza M and Khanna C (2009). Revisiting the seed and soil in cancer metastasis. Int J Biochem Cell Biol 41, 1452-1462.
5. Gray J, Evans N, Taylor B, Rizzo J, and Walker M (2009). State of the evidence: the connection between breast cancer and the environment. Int J Occup Environ Health 15, 43-78.
6. Wyckoff J, Wang W, Lin EY, Wang Y, Pixley F, Stanley ER, Graf T, Pollard JW, Segall J, and Condeelis J (2004). A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res 64, 7022-7029.
7. Lin EY, Gouon-Evans V, Nguyen AV, and Pollard JW (2002). The macrophage growth factor CSF-1 in mammary gland development and tumor progression. J Mammary Gland Biol Neoplasia 7, 147-162.
8. Joyce JA and Pollard JW (2009). Microenvironmental regulation of metastasis. Nat Rev Cancer 9, 239-252.
9. Sica A, Larghi P, Mancino A, Rubino L, Porta C, Totaro MG, Rimoldi M, Biswas SK, Allavena P, and Mantovani A (2008). Macrophage polarization in tumour progression. Semin Cancer Biol 18, 349-355.
10. Komohara Y, Ohnishi K, Kuratsu J, and Takeya M (2008). Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. J Pathol 216, 15-24.
11. Bingle L, Brown NJ, and Lewis CE (2002). The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 196, 254-265.
12. Chambers SK, Kacinski BM, Ivins CM, and Carcangiu ML (1997). Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1. Clin Cancer Res 3, 999-1007.
13. Leek RD, Talks KL, Pezzella F, Turley H, Campo L, Brown NS, Bicknell R, Taylor M, Gatter KC, and Harris AL (2002). Relation of hypoxia-inducible factor-2α (HIF-2α) expression in tumor-infiltrative macrophages to tumor angiogenesis and the oxidative thymidine phosphorylase pathway in human breast cancer. Cancer Res 62, 1326-1329.
14. Jin H, Aiyer A, Su J, Borgstrom P, Stupack D, Friedlander M, and Varner J (2006). A homing mechanism for bone marrow-derived progenitor cell recruitment to the neovasculature. J Clin Invest 116, 652-662.
15. Folkman J, Cole P, and Zimmerman S (1966). Tumor behavior in isolated perfused organs: in vitro growth and metastases of biopsy material in rabbit thyroid and canine intestinal segment. Ann Surg 164, 491-502.
16. Luo Y, Zhou H, Krueger J, Kaplan C, Lee SH, Dolman C, Markowitz D,Wu W, Liu C, Reisfeld RA, et al. (2006). Targeting tumor-associated macrophages as a novel strategy against breast cancer. J Clin Invest 116, 2132-2141.
17. Harmey JH, Dimitriadis E, Kay E, Redmond HP, and Bouchier-Hayes D (1998). Regulation of macrophage production of vascular endothelial growth factor (VEGF) by hypoxia and transforming growth factor β-1. Ann Surg Oncol 5, 271-278.
18. Wang W, Xu GL, Jia WD, Wang ZH, Li JS, Ma JL, Ge YS, Xie SX, and Yu JH (2009). Expression and correlation of hypoxia-inducible factor-1α, vascular endothelial growth factor and microvessel density in experimental rat hepatocarcinogenesis. J Int Med Res 37, 417-425.
19. Chen WT, Hung WC, Kang WY, Huang YC, Su YC, Yang CH, and Chai CY (2009). Overexpression of cyclooxygenase-2 in urothelial carcinoma in conjunction with tumor-associated-macrophage infiltration, hypoxia-inducible factor-1α expression, and tumor angiogenesis. APMIS 117, 176-184.
20. Kopfstein L andChristoforiG(2006).Metastasis: cell-autonomous mechanisms versus contributions by the tumor microenvironment. Cell Mol Life Sci 63, 449-468.
21. Stratford MR, Parkins CS, Everett SA, Dennis MF, Stubbs M, and Hill SA (1995). Analysis of the acidic microenvironment in murine tumours by high-performance ion chromatography. J Chromatogr A 706, 459-462.
22. Koukourakis MI, Giatromanolaki A, Harris AL, and Sivridis E (2006). Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma. Cancer Res 66, 632-637.
23. Schmitt-Graff A, Desmouliere A, and Gabbiani G (1994). Heterogeneity of myofibroblast phenotypic features: an example of fibroblastic cell plasticity. Virchows Arch 425, 3-24.
24. Deonarain R, Verma A, Porter AC, Gewert DR, Platanias LC, and Fish EN (2003). Critical roles for IFN-β in lymphoid development, myelopoiesis, and tumor development: links to tumor necrosis factor α. Proc Natl Acad Sci USA 100, 13453-13458.
25. Spaeth EL, Dembinski JL, Sasser AK, Watson K, Klopp A, Hall B, Andreeff M, and Marini F (2009). Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS One 4, e4992.
26. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL, and Weinberg RA (2005). Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121, 335-348.
27. Eck SM, Cote AL, Winkelman WD, and Brinckerhoff CE (2009). CXCR4 and matrix metalloproteinase-1 are elevated in breast carcinoma-associated fibroblasts and in normal mammary fibroblasts exposed to factors secreted by breast cancer cells. Mol Cancer Res 7, 1033-1044.
28. Okuyama N, Matsumine A, Kosugi R, Wakabayashi H, and Uchida A (2008). Matrix metalloproteinase-1 is a crucial bone metastasis factor in a human breast cancer-derived highly invasive cell line. Oncol Rep 20, 1497-1504.
29. de Jong JS, van Diest PJ, van der Valk P, and Baak JP (1998). Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis. J Pathol 184, 53-57.
30. Ma XJ, Dahiya S, Richardson E, Erlander M, and Sgroi DC (2009). Gene expression profiling of the tumor microenvironment during breast cancer progression. Breast Cancer Res 11, R7.
31. Montel V, Mose ES, and Tarin D (2006). Tumor-stromal interactions reciprocally modulate gene expression patterns during carcinogenesis and metastasis. Int J Cancer 119, 251-263.
32. Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H, Porter D, Hu M, Chin L, Richardson A, et al. (2004). Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6, 17-32.
33. Fukino K, Shen L, Patocs A, Mutter GL, and Eng C (2007). Genomic instability within tumor stroma and clinicopathological characteristics of sporadic primary invasive breast carcinoma. JAMA 297, 2103-2111.
34. Weber F, Shen L, Fukino K, Patocs A, Mutter GL, Caldes T, and Eng C (2006). Total-genome analysis of BRCA1/2-related invasive carcinomas of the breast identifies tumor stroma as potential landscaper for neoplastic initiation. Am J Hum Genet 78, 961-972.
35. Kurose K, Gilley K, Matsumoto S, Watson PH, Zhou XP, and Eng C (2002). Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. Nat Genet 32, 355-357.
36. Hu M, Yao J, Cai L, Bachman KE, van den Brule F, Velculescu V, and Polyak K (2005). Distinct epigenetic changes in the stromal cells of breast cancers. Nat Genet 37, 899-905.
37. Suzuki M, Shigematsu H, Shames DS, Sunaga N, Takahashi T, Shivapurkar N, Iizasa T, Minna JD, Fujisawa T, and Gazdar AF (2007). Methylation and gene silencing of the Ras-related GTPase gene in lung and breast cancers. Ann Surg Oncol 14, 1397-1404.
38. Hanson JA, Gillespie JW, Grover A, Tangrea MA, Chuaqui RF, Emmert-Buck MR, Tangrea JA, Libutti SK, Linehan WM, and Woodson KG (2006). Gene promoter methylation in prostate tumor-associated stromal cells. J Natl Cancer Inst 98, 255-261.
39. Ordway JM, Budiman MA, Korshunova Y, Maloney RK, Bedell JA, Citek RW, Bacher B, Peterson S, Rohlfing T, Hall J, et al. (2007). Identification of novel high-frequency DNA methylation changes in breast cancer. PLoS One 2, e1314.
40. Guo W and Giancotti FG (2004). Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 5, 816-826.
41. Byzova TV, Goldman CK, Pampori N, Thomas KA, Bett A, Shattil SJ, and Plow EF (2000). A mechanism for modulation of cellular responses to VEGF: activation of the integrins. Mol Cell 6, 851-860.
42. Klein S, Bikfalvi A, Birkenmeier TM, Giancotti FG, and Rifkin DB (1996). Integrin regulation by endogenous expression of 18-kDa fibroblast growth factor-2. J Biol Chem 271, 22583-22590.
43. 1 integrin and fibronectin in vascular development in mouse embryos and embryoid bodies. Arterioscler Thromb Vasc Biol 22, 927-933.
44. Fernandez-Sauze S, Grall D, Cseh B, and Van Obberghen-Schilling E (2009). Regulation of fibronectin matrix assembly and capillary morphogenesis in endothelial cells by Rho family GTPases. Exp Cell Res 315, 2092-2104.
45. Sun Z, Martinez-Lemus LA, Hill MA, and Meininger GA (2008). Extracellular matrix-specific focal adhesions in vascular smooth muscle produce mechanically active adhesion sites. Am J Physiol Cell Physiol 295, C268-C278.
46. 5 subunit and inhibits cell migration. J Cell Biol 151, 1141-1154.
47. Alahari SK (2003). Nischarin inhibits Rac induced migration and invasion of epithelial cells by affecting signaling cascades involving PAK. Exp Cell Res 288, 415-424.
48. Manser E, Huang HY, Loo TH, Chen XQ, Dong JM, Leung T, and Lim L (1997). Expression of constitutively active α-PAK reveals effects of the kinase on actin and focal complexes. Mol Cell Biol 17, 1129-1143.
49. 1-integrins on capillary tube formation in a human fibrinous matrix. Angiogenesis 12, 275-285.
50. 3. J Biol Chem 272, 2736-2743.
51. 1-VCAM-1-mediated adhesion between endothelial and mural cells is required for blood vessel maturation. J Clin Invest 115, 1542-1551.
52. 1 promotes monocyte trafficking and angiogenesis in tumors. Cancer Res 66, 2146-2152.
53. 1-deficient epithelial cells requires activation of members of the rho family of GTPases and downregulation of cadherin and catenin function. J Cell Biol 147, 1325-1340.
54. 1-integrin promotes type IV collagen degradation by breast and prostate cancer cells. Mol Imaging 7, 199-213.
55. 3. Cell 85, 683-693.
56. Kenny HA, Kaur S, Coussens LM, and Lengyel E (2008). The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin. J Clin Invest 118, 1367-1379.
57. 3 integrins at distinct cell compartments modulating its internalization and activity on human endothelial cells. J Cell Biol 159, 509-521.
58. 1. Mol Biol Cell 12, 2975-2986.
59. Baricos WH, Cortez SL, el-Dahr SS, and Schnaper HW (1995). ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade. Kidney Int 47, 1039-1047.
60. 1 dependent cell migration resistant to PI3K/Akt inhibition. Exp Cell Res 315, 1840-1849.
61. 1. Mol Cancer Ther 7, 2133-2141.
62. 3 to FGF1 plays a role in FGF1 signaling. J Biol Chem 283, 18066-18075.
63. Ao M, Williams K, Bhowmick NA, and Hayward SW (2006). Transforming growth factor-β promotes invasion in tumorigenic but not in nontumorigenic human prostatic epithelial cells. Cancer Res 66, 8007-8016.
64. Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, Shappell S, Washington MK, Neilson EG, and Moses HL (2004). TGF-β signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303, 848-851.
65. Kuperwasser C, Chavarria T,Wu M,Magrane G,Gray JW, Carey L, Richardson A, and Weinberg RA (2004). Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci USA 101, 4966-4971.
66. Ao M, Franco OE, Park D, Raman D, Williams K, and Hayward SW (2007). Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium. Cancer Res 67, 4244-4253.
67. Niu YN and Xia SJ (2009). Stroma-epithelium crosstalk in prostate cancer. Asian J Androl 11, 28-35.
68. Wang J, Sun Y, Song W, Nor JE, Wang CY, and Taichman RS (2005). Diverse signaling pathways through the SDF-1/CXCR4 chemokine axis in prostate cancer cell lines leads to altered patterns of cytokine secretion and angiogenesis. Cell Signal 17, 1578-1592.
69. 1 and CXCL12. Cancer Res 69, 3221-3227.